The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD

Authors

  • Jagoda Stojkovikj

  • Beti Ivanovska-Zafirovska

  • Irina Angelovska

  • Angela Debreslioska

  • Sead Zejnel

Keywords:

severe COPD, very severe COPD, risk factors, cardiovascular comorbidity

Abstract

Cardiovascular comorbidities are most frequent comorbidities in COPD and are responsible for many deaths in those patients. The aim of the study was to investigate the prevalence and the risk factors of these comorbidities. In the survey 114COPD patients were included with severe and very severe stage of the disease, FEV1

How to Cite

The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD. (2016). Global Journal of Medical Research, 16(15), 7-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Author Biographies

Jagoda Stojkovikj

Jagoda Stojkovikj is a dedicated researcher affiliated with the University Clinic of Pulmollogy and Allergology in Macedonia. Her work focuses on chronic obstructive pulmonary disease (COPD) and its cardiovascular comorbidities. She has authored key studies such as 'The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD' and 'The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.' With 11 publications and 68 citations, her research has contributed to understanding the interplay between respiratory and cardiovascular health. Her h-index of 3 and i10-index of 2 reflect her growing impact in the field.

Beti Ivanovska-Zafirovska

Beti Ivanovska-Zafirovska is a researcher affiliated with the University Clinic of Pulmollogy and Allergology in Skopje, Macedonia. Her work focuses on the intersection of respiratory diseases and cardiovascular health, as evidenced by her study on the prevalence and risk factors of cardiovascular comorbidity in patients with severe and very severe COPD. She has contributed to the medical literature with her research and continues to explore the complexities of chronic diseases.

Irina Angelovska

Irina Angelovska is a researcher affiliated with the University Clinic of Pulmollogy and Allergology in Skopje, Macedonia. Her work focuses on the intersection of respiratory and cardiovascular diseases, with a particular emphasis on the prevalence and risk factors of cardiovascular comorbidity in patients with severe and very severe COPD. She contributed to a study that sheds light on the clinical challenges faced by COPD patients, highlighting the importance of integrated care approaches. Her research underscores the need for comprehensive management strategies in chronic respiratory conditions.

Angela Debreslioska

Angela Debreslioska is a researcher affiliated with the University Clinic of Pulmollogy and Allergology in Skopje, Macedonia. She has contributed to the study of cardiovascular comorbidity in patients with severe and very severe COPD, co-authoring a paper on the prevalence and risk factors of this comorbidity. Her work focuses on the intersection of pulmonology and cardiology, highlighting the importance of integrated care for patients with chronic obstructive pulmonary disease.

Sead Zejnel

Sead Zejnel is a researcher affiliated with the University Clinic of Pulmollogy and Allergology in Skopje, Macedonia. His work focuses on respiratory diseases, particularly the interplay between chronic obstructive pulmonary disease (COPD) and cardiovascular comorbidities. He has contributed to studies examining the prevalence and risk factors of cardiovascular comorbidity in patients with severe and very severe COPD.

References

D. Mannino (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. 121(5), 121-126.

S. Sidney (2005) COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. 128(4). https://doi.org/10.1378/chest.128.4.2068

I. Andriana (2015) Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?. 46, 846-849.

C. Arnaud (2013) Comorbidities of COPD. 22, 454-475.

E. Dionne (2015) Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. 5(7), e007536. https://doi.org/10.1136/bmjopen-2014-007536

J. Izquierdo (2010) Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.Int J Chron Obstruct Pulmon Dis. 8(5), 387-394.

F. Michael (2012) Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). 679-686. https://doi.org/10.2147/COPD.S36222

W. VanDijk (2010) Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease. 74(2), 277-280. https://doi.org/10.1016/j.mehy.2009.09.012

Don Sin, S. Man (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. 83(1), 8-13. https://doi.org/10.1139/y04-116

Sin, S. D.D. Man (2008) Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. 14(2), 115-121. https://doi.org/10.1097/mcp.0b013e3282f45ffb

Martinez, C. Miguel, D. D.J.Mannino (2014) Defining COPD-related comorbidities. 1(1), 51-63. https://doi.org/10.15326/jcopdf.1.1.2014.0119

Peter Barnes (2010) Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs. 7(3), e1000220. https://doi.org/10.1371/journal.pmed.1000220

Don Sin, S. Man (2005) Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality. 2(1), 8-11. https://doi.org/10.1513/pats.200404-032ms

D. Mannino (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. 32(4), 962-969. https://doi.org/10.1183/09031936.00012408

R. Langen (2013) Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. 45(10), 2245-2256. https://doi.org/10.1016/j.biocel.2013.06.015

M. Donahoe (1989) Oxygen Consumption of the Respiratory Muscles in Normal and in Malnourished Patients with Chronic Obstructive Pulmonary Disease. 140(2), 385-391. https://doi.org/10.1164/ajrccm/140.2.385

M. Li Wei (2004) Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease. 141(10), 764-770. https://doi.org/10.7326/0003-4819-141-10-200411160-0000721

T. Perez (2015) Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. 10, 1663-1672. https://doi.org/10.2147/COPD.S8240822

H. Müllerová (2014) Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care. 9(1), 85540. https://doi.org/10.1371/journal.pone.008554

H. Van Remoortel1 (2014) Risk Factors and Comorbidities in the Preclinical Stages of Chronic Obstructive Pulmonary Disease. 189(1), 30-38. https://doi.org/10.1164/rccm.201307-1240oc

W. Chen (2015) Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. 9, 213-2600. https://doi.org/10.1016/s2213-2600(15)00241-6

L. Roever, E. Resende (2015) Cardiovascular Comorbidities in COPD Patients.

P. Jones (2013) Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. 42(3), 647-654. https://doi.org/10.1183/09031936.00125612

M. Masaki (2014) Analysis of comorbid factors that increase the COPD assessment test scores Respir. (1), 13. https://doi.org/10.1186/1465-9921-15-13

S. Leea (2014) The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. 108(4), 600-608. https://doi.org/10.1016/j.rmed.2013.12.014

P. Jones (2009) Development and first validation of the COPD Assessment Test. 34(3), 648-654. https://doi.org/10.1183/09031936.00102509

N. Sarioglua (2016) Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?. 22(1), 11-17. https://doi.org/10.1016/j.rppnen.2015.08.007

M. MacDonald (2016) Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. 4(2), 138-148. https://doi.org/10.1016/s2213-2600(15)00509-3

C. Terzano (2010) Comorbidity, Hospitalization, and Mortality in COPD: Results from a Longitudinal Study. 188(4), 321-329. https://doi.org/10.1007/s00408-009-9222-y

S. Man (2006) C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. 61(10), 849-853. https://doi.org/10.1136/thx.2006.059808

S. Patil (2003) In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease. 163(10), 1180. https://doi.org/10.1001/archinte.163.10.1180

A. Wong (2008) Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Influence of Social Factors in Determining Length of Hospital Stay and Readmission Rates. 15(7), 361-364. https://doi.org/10.1155/2008/569496

R. Kessler (1999) Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease. 159(1), 158-164. https://doi.org/10.1164/ajrccm.159.1.9803117

The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD

Published

2016-05-09

How to Cite

The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD. (2016). Global Journal of Medical Research, 16(15), 7-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/